MedTrace Logo

Integration of Wearable Sensor Devices Into a Single System to Predict the Onset of Sepsis

NCT07595848 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 360

Last updated 2026-05-19

No results posted yet for this study

Summary

The purpose of this clinical investigation is to evaluate the integration of data from the CPC12S telemonitoring device, the CPC temperature/humidity sensor, and the IDRO sweat lactate sensor into a single system for the prediction of sepsis onset in ICU patients at risk of developing sepsis. Patients will be monitored for up to 48 hours, and the collected physiological and biomarker data will be used to support the development of artificial intelligence and machine learning models for sepsis prediction.

Conditions

Interventions

DEVICE

CPC12S Telemonitoring System with Temperature/Humidity Sensor

The CPC12S telemonitoring system will be used together with the CPC temperature and humidity sensor to collect physiological parameters, body temperature, and humidity data from ICU patients during the monitoring period.

DEVICE

IDRO Sweat Lactate Sensor

The investigational IDRO sweat lactate sensor will be used to collect sweat lactate measurements. The sensor will be integrated with the CPC system for data transmission, visualization, and analysis.

Sponsors & Collaborators

  • Check Point R & D Ltd

    lead INDUSTRY

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-07-31
Primary Completion
2027-03-01
Completion
2027-03-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07595848 on ClinicalTrials.gov